Inotiv, Inc.
Inotiv, Inc. (NOTV) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
notv · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Inotiv, Inc.You NOTV | $3M | N/A | — | — |
 Biodesix, Inc. BDSX | $125M | N/A | — | -$4.67 |
 HeartBeam, Inc. BEAT | $28M | N/A | — | -$0.62 |
 bioAffinity Technologies, Inc. BIAF | $7M | N/A | — | -$8.66 |
 Celularity Inc. CELU | $19M | N/A | — | -$3.59 |
 FibroGen, Inc. FGEN | $37M | 0.19x | — | $45.38 |
 Kezar Life Sciences, Inc. KZR | $54M | N/A | — | -$7.66 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Inotiv, Inc. (NOTV) measures how much investors pay for each dollar of the company's trailing earnings. NOTV's current PE ratio of N/A is calculated by dividing its stock price of $0.08 by its TTM earnings per share of —.
Frequently asked questions
NOTV pe ratio · 6 questionsNOTV's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.08 and TTM EPS of —. Data sourced from Financial Modeling Prep via NOTV's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Inotiv, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09